Angiogenic Pathway Activation Multiple components contribute to blood vessel formation through distinct but complementary mechanisms: BPC-157 upregulates VEGFR2 expression and enhances endothelial cell proliferation TB-500 promotes endothelial cell migration and tube formation GHK-Cu stimulates angiogenic growth factor expression and vessel maturation Combined effects result in improved tissue vascularization and nutrient delivery Anti-Inflammatory Pathway Modulation The blend provides comprehensive inflammation control through multiple targets: BPC-157 modulates nitric oxide synthesis and reduces pro-inflammatory cytokines TB-500 influences inflammatory mediator expression through cytoskeletal mechanisms GHK-Cu reduces oxidative stress and modulates immune cell function Coordinated effects help resolve inflammation while promoting healing Synergistic Advantage: GLOW Blends multi-pathway approach enables simultaneous activation of cellular migration, matrix synthesis, angiogenesis, and inflammation control

Glutathione IV Benefits There are many great reasons to include glutathione IVs in your wellness routine
Formulated with the effective combination of 2% Glutathione and 3% Tranexamic Acid, this super serum improves the clarity and texture of the skin, thus encouraging an improved and healthy complexion
A study has revealed that total saponins of red ginseng lowered the number of cystic follicles and ovarian weight, and attenuated nerve growth factor (NGF) expressions in the ovaries, not in brain areas of the pituitary and hippocampus of estradiol valerate-induced PCOS rats
Glutathione helps suppress melanin production and promotes collagen synthesis, enhancing both skin brightness and overall skin health
The BPC-157 and TB-500 stack is best suited for: Athletes: Managing soft tissue injuries and wanting to accelerate return to training without compromising repair quality Post-surgical patients: Looking to improve tissue recovery quality and reduce scar formation Chronic tendinopathy patients: Who have not responded adequately to physical therapy alone Inflammation-driven conditions: Where systemic inflammatory signaling or gut permeability is part of the clinical picture The protocol is not appropriate for patients with active cancer or cancer history (growth factor upregulation is contraindicated), autoimmune disease where immune modulation carries additional risk, pregnancy or breastfeeding, or those with compromised liver or kidney function